MDxHealth SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by MDxHealth SA for the month of July 2023. The filing, dated July 3, 2023, serves to furnish a press release issued by the Company on June 30, 2023, which is attached as Exhibit 99.1.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a conduit for a press release rather than a financial statement itself.
Material Changes
The filing text does not disclose specific material changes versus prior periods. It references an attached press release (Exhibit 99.1) for the details of the announcement made on June 30, 2023.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. It explicitly states that the information in the attached press release is furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference except as expressly set forth.
Key Facts for Investor Verification
- Review the attached Exhibit 99.1 (Press Release dated June 30, 2023) for the actual content of the announcement.
- Note that the press release information is not deemed "filed" under Section 18 of the Exchange Act and carries different liability standards.
- Verify the Company's principal executive office location in Herstal, Belgium.
- Confirm that the registrant files annual reports under Form 20-F.